nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—migraine—epilepsy syndrome	0.178	1	CtDrD
Topiramate—GRIK5—epilepsy syndrome	0.0385	0.249	CbGaD
Topiramate—GRIA4—epilepsy syndrome	0.0292	0.189	CbGaD
Topiramate—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0284	0.222	CpDpCtD
Topiramate—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0284	0.222	CpDpCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Trimethadione—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Lamotrigine—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Oxcarbazepine—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Lacosamide—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Primidone—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Felbamate—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Fosphenytoin—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Levetiracetam—epilepsy syndrome	0.0238	0.0843	CiPCiCtD
Topiramate—GRIK1—epilepsy syndrome	0.0221	0.143	CbGaD
Topiramate—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0216	0.169	CpDpCtD
Topiramate—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.0203	0.0717	CiPCiCtD
Topiramate—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0183	0.143	CpDpCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—epilepsy syndrome	0.0181	0.0639	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—epilepsy syndrome	0.0181	0.0639	CiPCiCtD
Topiramate—bipolar disorder—Clonazepam—epilepsy syndrome	0.0172	0.135	CpDpCtD
Topiramate—bipolar disorder—Gabapentin—epilepsy syndrome	0.0139	0.109	CpDpCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Zonisamide—epilepsy syndrome	0.0137	0.0484	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Carbamazepine—epilepsy syndrome	0.0116	0.0412	CiPCiCtD
Topiramate—GRIA1—epilepsy syndrome	0.0108	0.0698	CbGaD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Phenytoin—epilepsy syndrome	0.0104	0.0367	CiPCiCtD
Topiramate—GRIA2—epilepsy syndrome	0.00962	0.0622	CbGaD
Topiramate—SCN1A—epilepsy syndrome	0.00832	0.0538	CbGaD
Topiramate—GABRG2—epilepsy syndrome	0.00804	0.0521	CbGaD
Topiramate—CA4—epilepsy syndrome	0.0078	0.0505	CbGaD
Topiramate—GRIK2—epilepsy syndrome	0.00636	0.0412	CbGaD
Topiramate—GABRB2—epilepsy syndrome	0.00567	0.0367	CbGaD
Topiramate—GABRA1—epilepsy syndrome	0.00556	0.036	CbGaD
Topiramate—GRIK2—Amobarbital—epilepsy syndrome	0.00454	0.0298	CbGbCtD
Topiramate—CA6—Lacosamide—epilepsy syndrome	0.00446	0.0293	CbGbCtD
Topiramate—GRIA2—Amobarbital—epilepsy syndrome	0.00431	0.0283	CbGbCtD
Topiramate—CA5B—Lacosamide—epilepsy syndrome	0.00389	0.0255	CbGbCtD
Topiramate—GRIK2—Primidone—epilepsy syndrome	0.00378	0.0248	CbGbCtD
Topiramate—GRIA2—Primidone—epilepsy syndrome	0.00359	0.0235	CbGbCtD
Topiramate—CA9—Lacosamide—epilepsy syndrome	0.00334	0.0219	CbGbCtD
Topiramate—SCN1A—Lamotrigine—epilepsy syndrome	0.00334	0.0219	CbGbCtD
Topiramate—GRIK2—Phenobarbital—epilepsy syndrome	0.00324	0.0212	CbGbCtD
Topiramate—SCN5A—Oxcarbazepine—epilepsy syndrome	0.00313	0.0205	CbGbCtD
Topiramate—CA1—Lacosamide—epilepsy syndrome	0.00312	0.0205	CbGbCtD
Topiramate—CA5A—Acetazolamide—epilepsy syndrome	0.00307	0.0202	CbGbCtD
Topiramate—GRIA2—Phenobarbital—epilepsy syndrome	0.00307	0.0202	CbGbCtD
Topiramate—CA6—Acetazolamide—epilepsy syndrome	0.00307	0.0202	CbGbCtD
Topiramate—SCN1A—Rufinamide—epilepsy syndrome	0.00295	0.0194	CbGbCtD
Topiramate—CA4—Lacosamide—epilepsy syndrome	0.00294	0.0193	CbGbCtD
Topiramate—CA6—Zonisamide—epilepsy syndrome	0.00284	0.0187	CbGbCtD
Topiramate—CA5A—Zonisamide—epilepsy syndrome	0.00284	0.0187	CbGbCtD
Topiramate—SCN5A—Fosphenytoin—epilepsy syndrome	0.00274	0.0179	CbGbCtD
Topiramate—CA2—Lacosamide—epilepsy syndrome	0.0027	0.0177	CbGbCtD
Topiramate—CA5B—Acetazolamide—epilepsy syndrome	0.00268	0.0176	CbGbCtD
Topiramate—CA7—Acetazolamide—epilepsy syndrome	0.00268	0.0176	CbGbCtD
Topiramate—CYP2C19—epilepsy syndrome	0.00261	0.0169	CbGaD
Topiramate—SCN1A—Phenytoin—epilepsy syndrome	0.00258	0.0169	CbGbCtD
Topiramate—CA7—Zonisamide—epilepsy syndrome	0.00248	0.0163	CbGbCtD
Topiramate—CA5B—Zonisamide—epilepsy syndrome	0.00248	0.0163	CbGbCtD
Topiramate—GABRB2—Clonazepam—epilepsy syndrome	0.00232	0.0153	CbGbCtD
Topiramate—CA12—Acetazolamide—epilepsy syndrome	0.0023	0.0151	CbGbCtD
Topiramate—CA9—Acetazolamide—epilepsy syndrome	0.0023	0.0151	CbGbCtD
Topiramate—SCN5A—Lamotrigine—epilepsy syndrome	0.00228	0.015	CbGbCtD
Topiramate—GABRB2—Clobazam—epilepsy syndrome	0.00223	0.0146	CbGbCtD
Topiramate—CA1—Acetazolamide—epilepsy syndrome	0.00215	0.0141	CbGbCtD
Topiramate—SCN1A—Zonisamide—epilepsy syndrome	0.00213	0.014	CbGbCtD
Topiramate—CA9—Zonisamide—epilepsy syndrome	0.00213	0.014	CbGbCtD
Topiramate—CA12—Zonisamide—epilepsy syndrome	0.00213	0.014	CbGbCtD
Topiramate—CA4—Acetazolamide—epilepsy syndrome	0.00202	0.0133	CbGbCtD
Topiramate—SCN5A—Rufinamide—epilepsy syndrome	0.00202	0.0132	CbGbCtD
Topiramate—CA1—Zonisamide—epilepsy syndrome	0.00199	0.0131	CbGbCtD
Topiramate—SCN5A—Carbamazepine—epilepsy syndrome	0.00197	0.0129	CbGbCtD
Topiramate—GABRG2—Clonazepam—epilepsy syndrome	0.00194	0.0128	CbGbCtD
Topiramate—CA4—Zonisamide—epilepsy syndrome	0.00187	0.0123	CbGbCtD
Topiramate—GABRG2—Clobazam—epilepsy syndrome	0.00186	0.0122	CbGbCtD
Topiramate—CA2—Acetazolamide—epilepsy syndrome	0.00186	0.0122	CbGbCtD
Topiramate—SCN5A—Phenytoin—epilepsy syndrome	0.00176	0.0116	CbGbCtD
Topiramate—GABRB2—Primidone—epilepsy syndrome	0.00172	0.0113	CbGbCtD
Topiramate—CA2—Zonisamide—epilepsy syndrome	0.00172	0.0113	CbGbCtD
Topiramate—GABRA1—Clonazepam—epilepsy syndrome	0.00162	0.0106	CbGbCtD
Topiramate—GABRA1—Clobazam—epilepsy syndrome	0.00155	0.0102	CbGbCtD
Topiramate—GABRB2—Propofol—epilepsy syndrome	0.00154	0.0101	CbGbCtD
Topiramate—GABRB2—Midazolam—epilepsy syndrome	0.00146	0.00955	CbGbCtD
Topiramate—SCN5A—Zonisamide—epilepsy syndrome	0.00145	0.00954	CbGbCtD
Topiramate—GABRG2—Primidone—epilepsy syndrome	0.00144	0.00946	CbGbCtD
Topiramate—GABRA1—Amobarbital—epilepsy syndrome	0.00144	0.00945	CbGbCtD
Topiramate—GABRB2—Diazepam—epilepsy syndrome	0.0014	0.00918	CbGbCtD
Topiramate—GRIA4—cerebellar cortex—epilepsy syndrome	0.00132	0.0647	CbGeAlD
Topiramate—GABRG2—Propofol—epilepsy syndrome	0.00129	0.00848	CbGbCtD
Topiramate—GABRG2—Midazolam—epilepsy syndrome	0.00122	0.00799	CbGbCtD
Topiramate—GABRA1—Primidone—epilepsy syndrome	0.0012	0.00786	CbGbCtD
Topiramate—GABRG2—Diazepam—epilepsy syndrome	0.00117	0.00768	CbGbCtD
Topiramate—GRIK1—cerebellar cortex—epilepsy syndrome	0.00116	0.0568	CbGeAlD
Topiramate—GABRA1—Propofol—epilepsy syndrome	0.00107	0.00705	CbGbCtD
Topiramate—GABRA1—Phenobarbital—epilepsy syndrome	0.00103	0.00673	CbGbCtD
Topiramate—GABRA1—Midazolam—epilepsy syndrome	0.00101	0.00664	CbGbCtD
Topiramate—GABRA1—Diazepam—epilepsy syndrome	0.000973	0.00638	CbGbCtD
Topiramate—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.000786	0.00516	CbGbCtD
Topiramate—CYP2C19—Trimethadione—epilepsy syndrome	0.000731	0.0048	CbGbCtD
Topiramate—CYP2C19—Felbamate—epilepsy syndrome	0.000731	0.0048	CbGbCtD
Topiramate—CYP2C19—Fosphenytoin—epilepsy syndrome	0.000687	0.00451	CbGbCtD
Topiramate—GRIK1—telencephalic ventricle—epilepsy syndrome	0.000672	0.033	CbGeAlD
Topiramate—CYP2C19—Clobazam—epilepsy syndrome	0.000596	0.00391	CbGbCtD
Topiramate—GRIA1—cerebellar cortex—epilepsy syndrome	0.000574	0.0282	CbGeAlD
Topiramate—CYP2C19—Carbamazepine—epilepsy syndrome	0.000494	0.00324	CbGbCtD
Topiramate—GRIA4—ganglion—epilepsy syndrome	0.000477	0.0234	CbGeAlD
Topiramate—CYP2C19—Primidone—epilepsy syndrome	0.000461	0.00302	CbGbCtD
Topiramate—CYP2C19—Phenytoin—epilepsy syndrome	0.000443	0.00291	CbGbCtD
Topiramate—GRIK1—ganglion—epilepsy syndrome	0.000418	0.0206	CbGeAlD
Topiramate—CYP2C19—Propofol—epilepsy syndrome	0.000413	0.00271	CbGbCtD
Topiramate—GRIK2—cerebellar cortex—epilepsy syndrome	0.000412	0.0202	CbGeAlD
Topiramate—CYP2C19—Phenobarbital—epilepsy syndrome	0.000395	0.00259	CbGbCtD
Topiramate—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00038	0.00249	CbGbCtD
Topiramate—CYP2C19—Diazepam—epilepsy syndrome	0.000374	0.00246	CbGbCtD
Topiramate—CYP2C19—Zonisamide—epilepsy syndrome	0.000365	0.0024	CbGbCtD
Topiramate—GRIA4—hindbrain—epilepsy syndrome	0.000362	0.0178	CbGeAlD
Topiramate—CYP3A4—Felbamate—epilepsy syndrome	0.000353	0.00232	CbGbCtD
Topiramate—CYP3A4—Trimethadione—epilepsy syndrome	0.000353	0.00232	CbGbCtD
Topiramate—CA6—ear—epilepsy syndrome	0.000334	0.0164	CbGeAlD
Topiramate—GRIK5—hindbrain—epilepsy syndrome	0.000334	0.0164	CbGeAlD
Topiramate—GRIA1—telencephalic ventricle—epilepsy syndrome	0.000334	0.0164	CbGeAlD
Topiramate—CYP3A4—Fosphenytoin—epilepsy syndrome	0.000332	0.00218	CbGbCtD
Topiramate—GRIK1—hindbrain—epilepsy syndrome	0.000317	0.0156	CbGeAlD
Topiramate—CYP3A4—Clonazepam—epilepsy syndrome	0.0003	0.00197	CbGbCtD
Topiramate—CYP2C19—Valproic Acid—epilepsy syndrome	0.000295	0.00194	CbGbCtD
Topiramate—CYP3A4—Clobazam—epilepsy syndrome	0.000288	0.00189	CbGbCtD
Topiramate—GRIK4—forebrain—epilepsy syndrome	0.000253	0.0124	CbGeAlD
Topiramate—CYP3A4—Rufinamide—epilepsy syndrome	0.000245	0.00161	CbGbCtD
Topiramate—GRIK2—telencephalic ventricle—epilepsy syndrome	0.000239	0.0118	CbGeAlD
Topiramate—CYP3A4—Carbamazepine—epilepsy syndrome	0.000239	0.00157	CbGbCtD
Topiramate—GRIK4—telencephalon—epilepsy syndrome	0.000233	0.0114	CbGeAlD
Topiramate—CYP3A4—Primidone—epilepsy syndrome	0.000223	0.00146	CbGbCtD
Topiramate—CYP3A4—Phenytoin—epilepsy syndrome	0.000214	0.0014	CbGbCtD
Topiramate—GRIA1—ganglion—epilepsy syndrome	0.000208	0.0102	CbGeAlD
Topiramate—GRIA4—brainstem—epilepsy syndrome	0.000207	0.0102	CbGeAlD
Topiramate—GRIA4—forebrain—epilepsy syndrome	0.0002	0.00983	CbGeAlD
Topiramate—CYP3A4—Propofol—epilepsy syndrome	0.0002	0.00131	CbGbCtD
Topiramate—GRIK5—brainstem—epilepsy syndrome	0.000191	0.0094	CbGeAlD
Topiramate—CYP3A4—Acetazolamide—epilepsy syndrome	0.000191	0.00125	CbGbCtD
Topiramate—CYP3A4—Phenobarbital—epilepsy syndrome	0.000191	0.00125	CbGbCtD
Topiramate—CYP3A4—Midazolam—epilepsy syndrome	0.000188	0.00123	CbGbCtD
Topiramate—GRIK5—forebrain—epilepsy syndrome	0.000185	0.00908	CbGeAlD
Topiramate—GRIK3—forebrain—epilepsy syndrome	0.000185	0.00908	CbGeAlD
Topiramate—GRIA4—telencephalon—epilepsy syndrome	0.000184	0.00904	CbGeAlD
Topiramate—GRIK1—brainstem—epilepsy syndrome	0.000182	0.00893	CbGeAlD
Topiramate—CYP3A4—Diazepam—epilepsy syndrome	0.000181	0.00119	CbGbCtD
Topiramate—CYP3A4—Zonisamide—epilepsy syndrome	0.000177	0.00116	CbGbCtD
Topiramate—GRIK1—forebrain—epilepsy syndrome	0.000176	0.00862	CbGeAlD
Topiramate—GRIK5—telencephalon—epilepsy syndrome	0.00017	0.00835	CbGeAlD
Topiramate—GRIK3—telencephalon—epilepsy syndrome	0.00017	0.00835	CbGeAlD
Topiramate—GRIA2—ganglion—epilepsy syndrome	0.000165	0.00811	CbGeAlD
Topiramate—GRIA3—forebrain—epilepsy syndrome	0.000163	0.00802	CbGeAlD
Topiramate—GRIK1—telencephalon—epilepsy syndrome	0.000161	0.00793	CbGeAlD
Topiramate—GRIA1—hindbrain—epilepsy syndrome	0.000158	0.00774	CbGeAlD
Topiramate—GRIA3—telencephalon—epilepsy syndrome	0.00015	0.00737	CbGeAlD
Topiramate—GRIK2—ganglion—epilepsy syndrome	0.000149	0.00732	CbGeAlD
Topiramate—GRIK4—head—epilepsy syndrome	0.000145	0.00712	CbGeAlD
Topiramate—GRIA4—medulla oblongata—epilepsy syndrome	0.000145	0.0071	CbGeAlD
Topiramate—CYP3A4—Valproic Acid—epilepsy syndrome	0.000143	0.000936	CbGbCtD
Topiramate—GRIK4—nervous system—epilepsy syndrome	0.000137	0.00675	CbGeAlD
Topiramate—GRIK5—medulla oblongata—epilepsy syndrome	0.000133	0.00656	CbGeAlD
Topiramate—GRIK3—medulla oblongata—epilepsy syndrome	0.000133	0.00656	CbGeAlD
Topiramate—GRIK4—central nervous system—epilepsy syndrome	0.000132	0.0065	CbGeAlD
Topiramate—GRIK4—cerebellum—epilepsy syndrome	0.000129	0.00636	CbGeAlD
Topiramate—GRIA4—spinal cord—epilepsy syndrome	0.000129	0.00634	CbGeAlD
Topiramate—GRIK1—medulla oblongata—epilepsy syndrome	0.000127	0.00623	CbGeAlD
Topiramate—GRIA2—hindbrain—epilepsy syndrome	0.000125	0.00615	CbGeAlD
Topiramate—GRIK3—midbrain—epilepsy syndrome	0.000122	0.00599	CbGeAlD
Topiramate—GRIK5—midbrain—epilepsy syndrome	0.000122	0.00599	CbGeAlD
Topiramate—GRIK5—spinal cord—epilepsy syndrome	0.000119	0.00585	CbGeAlD
Topiramate—GRIK3—spinal cord—epilepsy syndrome	0.000119	0.00585	CbGeAlD
Topiramate—GRIA3—medulla oblongata—epilepsy syndrome	0.000118	0.00579	CbGeAlD
Topiramate—GRIK1—midbrain—epilepsy syndrome	0.000116	0.00569	CbGeAlD
Topiramate—GRIA4—head—epilepsy syndrome	0.000115	0.00563	CbGeAlD
Topiramate—SCN1A—hindbrain—epilepsy syndrome	0.000114	0.00561	CbGeAlD
Topiramate—GRIK1—spinal cord—epilepsy syndrome	0.000113	0.00556	CbGeAlD
Topiramate—GRIK2—hindbrain—epilepsy syndrome	0.000113	0.00555	CbGeAlD
Topiramate—GRIA4—nervous system—epilepsy syndrome	0.000109	0.00534	CbGeAlD
Topiramate—GRIA3—midbrain—epilepsy syndrome	0.000108	0.00529	CbGeAlD
Topiramate—GRIK5—head—epilepsy syndrome	0.000106	0.0052	CbGeAlD
Topiramate—GRIK3—head—epilepsy syndrome	0.000106	0.0052	CbGeAlD
Topiramate—GRIA3—spinal cord—epilepsy syndrome	0.000105	0.00516	CbGeAlD
Topiramate—GRIK4—brain—epilepsy syndrome	0.000105	0.00516	CbGeAlD
Topiramate—GRIA4—central nervous system—epilepsy syndrome	0.000105	0.00514	CbGeAlD
Topiramate—GRIA4—cerebellum—epilepsy syndrome	0.000102	0.00502	CbGeAlD
Topiramate—GRIK1—head—epilepsy syndrome	0.000101	0.00494	CbGeAlD
Topiramate—GRIK5—nervous system—epilepsy syndrome	0.0001	0.00493	CbGeAlD
Topiramate—GRIK3—nervous system—epilepsy syndrome	0.0001	0.00493	CbGeAlD
Topiramate—GRIK5—central nervous system—epilepsy syndrome	9.66e-05	0.00474	CbGeAlD
Topiramate—GRIK3—central nervous system—epilepsy syndrome	9.66e-05	0.00474	CbGeAlD
Topiramate—GRIK1—nervous system—epilepsy syndrome	9.53e-05	0.00468	CbGeAlD
Topiramate—GRIK3—cerebellum—epilepsy syndrome	9.44e-05	0.00464	CbGeAlD
Topiramate—GRIK5—cerebellum—epilepsy syndrome	9.44e-05	0.00464	CbGeAlD
Topiramate—GRIA3—head—epilepsy syndrome	9.34e-05	0.00459	CbGeAlD
Topiramate—GRIK1—central nervous system—epilepsy syndrome	9.17e-05	0.00451	CbGeAlD
Topiramate—GRIA1—brainstem—epilepsy syndrome	9.03e-05	0.00444	CbGeAlD
Topiramate—GRIK1—cerebellum—epilepsy syndrome	8.97e-05	0.00441	CbGeAlD
Topiramate—GABRB2—hindbrain—epilepsy syndrome	8.9e-05	0.00437	CbGeAlD
Topiramate—GRIA3—nervous system—epilepsy syndrome	8.86e-05	0.00435	CbGeAlD
Topiramate—GRIA1—forebrain—epilepsy syndrome	8.71e-05	0.00428	CbGeAlD
Topiramate—CA4—ganglion—epilepsy syndrome	8.62e-05	0.00424	CbGeAlD
Topiramate—GRIA3—central nervous system—epilepsy syndrome	8.53e-05	0.00419	CbGeAlD
Topiramate—GRIA3—cerebellum—epilepsy syndrome	8.34e-05	0.0041	CbGeAlD
Topiramate—GRIA4—brain—epilepsy syndrome	8.31e-05	0.00408	CbGeAlD
Topiramate—GRIA1—telencephalon—epilepsy syndrome	8.01e-05	0.00394	CbGeAlD
Topiramate—GABRA1—hindbrain—epilepsy syndrome	7.86e-05	0.00386	CbGeAlD
Topiramate—GRIK3—brain—epilepsy syndrome	7.67e-05	0.00377	CbGeAlD
Topiramate—GRIK5—brain—epilepsy syndrome	7.67e-05	0.00377	CbGeAlD
Topiramate—GRIK1—brain—epilepsy syndrome	7.28e-05	0.00358	CbGeAlD
Topiramate—GRIA2—brainstem—epilepsy syndrome	7.17e-05	0.00352	CbGeAlD
Topiramate—GRIA2—forebrain—epilepsy syndrome	6.92e-05	0.0034	CbGeAlD
Topiramate—GRIA3—brain—epilepsy syndrome	6.77e-05	0.00333	CbGeAlD
Topiramate—SCN1A—brainstem—epilepsy syndrome	6.54e-05	0.00321	CbGeAlD
Topiramate—CA4—hindbrain—epilepsy syndrome	6.54e-05	0.00321	CbGeAlD
Topiramate—GRIK2—brainstem—epilepsy syndrome	6.48e-05	0.00318	CbGeAlD
Topiramate—GRIA2—telencephalon—epilepsy syndrome	6.36e-05	0.00313	CbGeAlD
Topiramate—SCN1A—forebrain—epilepsy syndrome	6.32e-05	0.0031	CbGeAlD
Topiramate—GRIA1—medulla oblongata—epilepsy syndrome	6.3e-05	0.00309	CbGeAlD
Topiramate—GRIK2—forebrain—epilepsy syndrome	6.25e-05	0.00307	CbGeAlD
Topiramate—CA7—midbrain—epilepsy syndrome	5.94e-05	0.00292	CbGeAlD
Topiramate—CA12—forebrain—epilepsy syndrome	5.84e-05	0.00287	CbGeAlD
Topiramate—SCN1A—telencephalon—epilepsy syndrome	5.81e-05	0.00285	CbGeAlD
Topiramate—GRIA1—midbrain—epilepsy syndrome	5.75e-05	0.00283	CbGeAlD
Topiramate—GRIK2—telencephalon—epilepsy syndrome	5.75e-05	0.00282	CbGeAlD
Topiramate—GRIA1—spinal cord—epilepsy syndrome	5.61e-05	0.00276	CbGeAlD
Topiramate—CA2—hindbrain—epilepsy syndrome	5.42e-05	0.00266	CbGeAlD
Topiramate—CA12—telencephalon—epilepsy syndrome	5.37e-05	0.00264	CbGeAlD
Topiramate—GABRB2—brainstem—epilepsy syndrome	5.1e-05	0.00251	CbGeAlD
Topiramate—GRIA1—head—epilepsy syndrome	4.99e-05	0.00245	CbGeAlD
Topiramate—CA6—head—epilepsy syndrome	4.99e-05	0.00245	CbGeAlD
Topiramate—GABRB2—forebrain—epilepsy syndrome	4.92e-05	0.00242	CbGeAlD
Topiramate—GABRG2—forebrain—epilepsy syndrome	4.92e-05	0.00242	CbGeAlD
Topiramate—GRIA1—nervous system—epilepsy syndrome	4.73e-05	0.00232	CbGeAlD
Topiramate—CA1—forebrain—epilepsy syndrome	4.63e-05	0.00227	CbGeAlD
Topiramate—CA7—cerebellum—epilepsy syndrome	4.59e-05	0.00226	CbGeAlD
Topiramate—GRIA2—midbrain—epilepsy syndrome	4.57e-05	0.00225	CbGeAlD
Topiramate—SCN1A—medulla oblongata—epilepsy syndrome	4.56e-05	0.00224	CbGeAlD
Topiramate—GRIA1—central nervous system—epilepsy syndrome	4.55e-05	0.00224	CbGeAlD
Topiramate—GABRB2—telencephalon—epilepsy syndrome	4.53e-05	0.00222	CbGeAlD
Topiramate—GABRG2—telencephalon—epilepsy syndrome	4.53e-05	0.00222	CbGeAlD
Topiramate—GRIK2—medulla oblongata—epilepsy syndrome	4.52e-05	0.00222	CbGeAlD
Topiramate—GABRA1—brainstem—epilepsy syndrome	4.5e-05	0.00221	CbGeAlD
Topiramate—GRIA2—spinal cord—epilepsy syndrome	4.46e-05	0.00219	CbGeAlD
Topiramate—GRIA1—cerebellum—epilepsy syndrome	4.45e-05	0.00219	CbGeAlD
Topiramate—GABRA1—forebrain—epilepsy syndrome	4.35e-05	0.00214	CbGeAlD
Topiramate—CA1—telencephalon—epilepsy syndrome	4.26e-05	0.00209	CbGeAlD
Topiramate—SCN1A—midbrain—epilepsy syndrome	4.17e-05	0.00205	CbGeAlD
Topiramate—GRIK2—midbrain—epilepsy syndrome	4.13e-05	0.00203	CbGeAlD
Topiramate—SCN1A—spinal cord—epilepsy syndrome	4.07e-05	0.002	CbGeAlD
Topiramate—CA9—cerebellum—epilepsy syndrome	4.04e-05	0.00198	CbGeAlD
Topiramate—GRIK2—spinal cord—epilepsy syndrome	4.03e-05	0.00198	CbGeAlD
Topiramate—GABRA1—telencephalon—epilepsy syndrome	4e-05	0.00196	CbGeAlD
Topiramate—GRIA2—head—epilepsy syndrome	3.96e-05	0.00195	CbGeAlD
Topiramate—GRIA2—nervous system—epilepsy syndrome	3.76e-05	0.00185	CbGeAlD
Topiramate—CA4—brainstem—epilepsy syndrome	3.75e-05	0.00184	CbGeAlD
Topiramate—CA7—brain—epilepsy syndrome	3.73e-05	0.00183	CbGeAlD
Topiramate—CA4—forebrain—epilepsy syndrome	3.62e-05	0.00178	CbGeAlD
Topiramate—GRIA2—central nervous system—epilepsy syndrome	3.62e-05	0.00178	CbGeAlD
Topiramate—SCN1A—head—epilepsy syndrome	3.62e-05	0.00178	CbGeAlD
Topiramate—GRIA1—brain—epilepsy syndrome	3.62e-05	0.00178	CbGeAlD
Topiramate—GRIK2—head—epilepsy syndrome	3.58e-05	0.00176	CbGeAlD
Topiramate—GABRB2—medulla oblongata—epilepsy syndrome	3.56e-05	0.00175	CbGeAlD
Topiramate—GABRG2—medulla oblongata—epilepsy syndrome	3.56e-05	0.00175	CbGeAlD
Topiramate—GRIA2—cerebellum—epilepsy syndrome	3.54e-05	0.00174	CbGeAlD
Topiramate—SCN1A—nervous system—epilepsy syndrome	3.43e-05	0.00168	CbGeAlD
Topiramate—GRIK2—nervous system—epilepsy syndrome	3.39e-05	0.00167	CbGeAlD
Topiramate—CA12—head—epilepsy syndrome	3.35e-05	0.00164	CbGeAlD
Topiramate—CA4—telencephalon—epilepsy syndrome	3.33e-05	0.00163	CbGeAlD
Topiramate—SCN1A—central nervous system—epilepsy syndrome	3.3e-05	0.00162	CbGeAlD
Topiramate—GRIK2—central nervous system—epilepsy syndrome	3.27e-05	0.00161	CbGeAlD
Topiramate—GABRB2—midbrain—epilepsy syndrome	3.25e-05	0.0016	CbGeAlD
Topiramate—GABRG2—midbrain—epilepsy syndrome	3.25e-05	0.0016	CbGeAlD
Topiramate—SCN1A—cerebellum—epilepsy syndrome	3.23e-05	0.00158	CbGeAlD
Topiramate—GRIK2—cerebellum—epilepsy syndrome	3.19e-05	0.00157	CbGeAlD
Topiramate—CA12—nervous system—epilepsy syndrome	3.17e-05	0.00156	CbGeAlD
Topiramate—GABRG2—spinal cord—epilepsy syndrome	3.17e-05	0.00156	CbGeAlD
Topiramate—GABRB2—spinal cord—epilepsy syndrome	3.17e-05	0.00156	CbGeAlD
Topiramate—GABRA1—medulla oblongata—epilepsy syndrome	3.14e-05	0.00154	CbGeAlD
Topiramate—CA2—brainstem—epilepsy syndrome	3.11e-05	0.00153	CbGeAlD
Topiramate—CA12—central nervous system—epilepsy syndrome	3.05e-05	0.0015	CbGeAlD
Topiramate—CA5B—head—epilepsy syndrome	3e-05	0.00147	CbGeAlD
Topiramate—CA2—forebrain—epilepsy syndrome	3e-05	0.00147	CbGeAlD
Topiramate—CA1—spinal cord—epilepsy syndrome	2.98e-05	0.00147	CbGeAlD
Topiramate—SCN5A—head—epilepsy syndrome	2.91e-05	0.00143	CbGeAlD
Topiramate—GRIA2—brain—epilepsy syndrome	2.87e-05	0.00141	CbGeAlD
Topiramate—GABRA1—midbrain—epilepsy syndrome	2.87e-05	0.00141	CbGeAlD
Topiramate—CA5B—nervous system—epilepsy syndrome	2.85e-05	0.0014	CbGeAlD
Topiramate—GABRB2—head—epilepsy syndrome	2.82e-05	0.00138	CbGeAlD
Topiramate—GABRG2—head—epilepsy syndrome	2.82e-05	0.00138	CbGeAlD
Topiramate—GABRA1—spinal cord—epilepsy syndrome	2.8e-05	0.00138	CbGeAlD
Topiramate—CA2—telencephalon—epilepsy syndrome	2.76e-05	0.00136	CbGeAlD
Topiramate—SCN5A—nervous system—epilepsy syndrome	2.76e-05	0.00135	CbGeAlD
Topiramate—CA5B—central nervous system—epilepsy syndrome	2.74e-05	0.00135	CbGeAlD
Topiramate—GABRB2—nervous system—epilepsy syndrome	2.67e-05	0.00131	CbGeAlD
Topiramate—GABRG2—nervous system—epilepsy syndrome	2.67e-05	0.00131	CbGeAlD
Topiramate—SCN5A—central nervous system—epilepsy syndrome	2.65e-05	0.0013	CbGeAlD
Topiramate—CA1—head—epilepsy syndrome	2.65e-05	0.0013	CbGeAlD
Topiramate—SCN1A—brain—epilepsy syndrome	2.62e-05	0.00129	CbGeAlD
Topiramate—CA4—medulla oblongata—epilepsy syndrome	2.61e-05	0.00128	CbGeAlD
Topiramate—GRIK2—brain—epilepsy syndrome	2.59e-05	0.00127	CbGeAlD
Topiramate—GABRB2—central nervous system—epilepsy syndrome	2.57e-05	0.00126	CbGeAlD
Topiramate—GABRG2—central nervous system—epilepsy syndrome	2.57e-05	0.00126	CbGeAlD
Topiramate—GABRB2—cerebellum—epilepsy syndrome	2.52e-05	0.00124	CbGeAlD
Topiramate—GABRG2—cerebellum—epilepsy syndrome	2.52e-05	0.00124	CbGeAlD
Topiramate—CA1—nervous system—epilepsy syndrome	2.51e-05	0.00123	CbGeAlD
Topiramate—GABRA1—head—epilepsy syndrome	2.49e-05	0.00122	CbGeAlD
Topiramate—CA12—brain—epilepsy syndrome	2.42e-05	0.00119	CbGeAlD
Topiramate—CA1—central nervous system—epilepsy syndrome	2.42e-05	0.00119	CbGeAlD
Topiramate—CA4—midbrain—epilepsy syndrome	2.39e-05	0.00117	CbGeAlD
Topiramate—GABRA1—nervous system—epilepsy syndrome	2.36e-05	0.00116	CbGeAlD
Topiramate—CA4—spinal cord—epilepsy syndrome	2.33e-05	0.00115	CbGeAlD
Topiramate—GABRA1—central nervous system—epilepsy syndrome	2.27e-05	0.00112	CbGeAlD
Topiramate—GABRA1—cerebellum—epilepsy syndrome	2.22e-05	0.00109	CbGeAlD
Topiramate—CA5B—brain—epilepsy syndrome	2.17e-05	0.00107	CbGeAlD
Topiramate—CA2—medulla oblongata—epilepsy syndrome	2.17e-05	0.00106	CbGeAlD
Topiramate—SCN5A—brain—epilepsy syndrome	2.11e-05	0.00104	CbGeAlD
Topiramate—CA4—head—epilepsy syndrome	2.07e-05	0.00102	CbGeAlD
Topiramate—GABRB2—brain—epilepsy syndrome	2.04e-05	0.001	CbGeAlD
Topiramate—GABRG2—brain—epilepsy syndrome	2.04e-05	0.001	CbGeAlD
Topiramate—CA2—midbrain—epilepsy syndrome	1.98e-05	0.000973	CbGeAlD
Topiramate—CA4—nervous system—epilepsy syndrome	1.96e-05	0.000965	CbGeAlD
Topiramate—CA2—spinal cord—epilepsy syndrome	1.93e-05	0.00095	CbGeAlD
Topiramate—CA1—brain—epilepsy syndrome	1.92e-05	0.000944	CbGeAlD
Topiramate—CA4—central nervous system—epilepsy syndrome	1.89e-05	0.000929	CbGeAlD
Topiramate—CA4—cerebellum—epilepsy syndrome	1.85e-05	0.000908	CbGeAlD
Topiramate—GABRA1—brain—epilepsy syndrome	1.8e-05	0.000886	CbGeAlD
Topiramate—CA2—head—epilepsy syndrome	1.72e-05	0.000844	CbGeAlD
Topiramate—CA2—nervous system—epilepsy syndrome	1.63e-05	0.0008	CbGeAlD
Topiramate—CA2—central nervous system—epilepsy syndrome	1.57e-05	0.00077	CbGeAlD
Topiramate—CA2—cerebellum—epilepsy syndrome	1.53e-05	0.000753	CbGeAlD
Topiramate—CA4—brain—epilepsy syndrome	1.5e-05	0.000738	CbGeAlD
Topiramate—CA2—brain—epilepsy syndrome	1.24e-05	0.000612	CbGeAlD
Topiramate—CYP3A4—nervous system—epilepsy syndrome	1.05e-05	0.000516	CbGeAlD
Topiramate—CYP3A4—central nervous system—epilepsy syndrome	1.01e-05	0.000497	CbGeAlD
Topiramate—Rash—Levetiracetam—epilepsy syndrome	3.79e-06	8.05e-05	CcSEcCtD
Topiramate—Anaemia—Pregabalin—epilepsy syndrome	3.79e-06	8.05e-05	CcSEcCtD
Topiramate—Dermatitis—Levetiracetam—epilepsy syndrome	3.79e-06	8.04e-05	CcSEcCtD
Topiramate—Asthenia—Zonisamide—epilepsy syndrome	3.79e-06	8.04e-05	CcSEcCtD
Topiramate—Mental disorder—Gabapentin—epilepsy syndrome	3.79e-06	8.04e-05	CcSEcCtD
Topiramate—Dry mouth—Valproic Acid—epilepsy syndrome	3.78e-06	8.02e-05	CcSEcCtD
Topiramate—Agitation—Pregabalin—epilepsy syndrome	3.77e-06	8e-05	CcSEcCtD
Topiramate—Headache—Levetiracetam—epilepsy syndrome	3.77e-06	8e-05	CcSEcCtD
Topiramate—Malnutrition—Gabapentin—epilepsy syndrome	3.76e-06	7.99e-05	CcSEcCtD
Topiramate—Erythema—Gabapentin—epilepsy syndrome	3.76e-06	7.99e-05	CcSEcCtD
Topiramate—Hypersensitivity—Clonazepam—epilepsy syndrome	3.75e-06	7.95e-05	CcSEcCtD
Topiramate—Dizziness—Vigabatrin—epilepsy syndrome	3.74e-06	7.94e-05	CcSEcCtD
Topiramate—Confusional state—Valproic Acid—epilepsy syndrome	3.73e-06	7.93e-05	CcSEcCtD
Topiramate—Pruritus—Zonisamide—epilepsy syndrome	3.73e-06	7.93e-05	CcSEcCtD
Topiramate—Hypersensitivity—Phenytoin—epilepsy syndrome	3.72e-06	7.9e-05	CcSEcCtD
Topiramate—Flatulence—Gabapentin—epilepsy syndrome	3.71e-06	7.87e-05	CcSEcCtD
Topiramate—Oedema—Valproic Acid—epilepsy syndrome	3.7e-06	7.86e-05	CcSEcCtD
Topiramate—Urticaria—Lamotrigine—epilepsy syndrome	3.7e-06	7.86e-05	CcSEcCtD
Topiramate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.7e-06	7.86e-05	CcSEcCtD
Topiramate—Malaise—Pregabalin—epilepsy syndrome	3.7e-06	7.85e-05	CcSEcCtD
Topiramate—Nausea—Propofol—epilepsy syndrome	3.7e-06	7.85e-05	CcSEcCtD
Topiramate—Tension—Gabapentin—epilepsy syndrome	3.69e-06	7.84e-05	CcSEcCtD
Topiramate—Vomiting—Fosphenytoin—epilepsy syndrome	3.69e-06	7.83e-05	CcSEcCtD
Topiramate—Diarrhoea—Felbamate—epilepsy syndrome	3.69e-06	7.83e-05	CcSEcCtD
Topiramate—Vertigo—Pregabalin—epilepsy syndrome	3.69e-06	7.82e-05	CcSEcCtD
Topiramate—Abdominal pain—Lamotrigine—epilepsy syndrome	3.68e-06	7.82e-05	CcSEcCtD
Topiramate—Body temperature increased—Lamotrigine—epilepsy syndrome	3.68e-06	7.82e-05	CcSEcCtD
Topiramate—Dysgeusia—Gabapentin—epilepsy syndrome	3.68e-06	7.82e-05	CcSEcCtD
Topiramate—Dizziness—Diazepam—epilepsy syndrome	3.68e-06	7.82e-05	CcSEcCtD
Topiramate—Infection—Valproic Acid—epilepsy syndrome	3.68e-06	7.81e-05	CcSEcCtD
Topiramate—Syncope—Pregabalin—epilepsy syndrome	3.68e-06	7.81e-05	CcSEcCtD
Topiramate—Leukopenia—Pregabalin—epilepsy syndrome	3.67e-06	7.79e-05	CcSEcCtD
Topiramate—Rash—Fosphenytoin—epilepsy syndrome	3.66e-06	7.77e-05	CcSEcCtD
Topiramate—Dermatitis—Fosphenytoin—epilepsy syndrome	3.66e-06	7.76e-05	CcSEcCtD
Topiramate—Nervousness—Gabapentin—epilepsy syndrome	3.65e-06	7.76e-05	CcSEcCtD
Topiramate—Asthenia—Clonazepam—epilepsy syndrome	3.65e-06	7.75e-05	CcSEcCtD
Topiramate—Back pain—Gabapentin—epilepsy syndrome	3.64e-06	7.72e-05	CcSEcCtD
Topiramate—Headache—Fosphenytoin—epilepsy syndrome	3.64e-06	7.72e-05	CcSEcCtD
Topiramate—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.63e-06	7.71e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.63e-06	7.7e-05	CcSEcCtD
Topiramate—Palpitations—Pregabalin—epilepsy syndrome	3.62e-06	7.7e-05	CcSEcCtD
Topiramate—Asthenia—Phenytoin—epilepsy syndrome	3.62e-06	7.69e-05	CcSEcCtD
Topiramate—Nausea—Midazolam—epilepsy syndrome	3.62e-06	7.68e-05	CcSEcCtD
Topiramate—Muscle spasms—Gabapentin—epilepsy syndrome	3.62e-06	7.68e-05	CcSEcCtD
Topiramate—Tachycardia—Valproic Acid—epilepsy syndrome	3.61e-06	7.67e-05	CcSEcCtD
Topiramate—Diarrhoea—Zonisamide—epilepsy syndrome	3.61e-06	7.66e-05	CcSEcCtD
Topiramate—Loss of consciousness—Pregabalin—epilepsy syndrome	3.61e-06	7.65e-05	CcSEcCtD
Topiramate—Asthenia—Oxcarbazepine—epilepsy syndrome	3.61e-06	7.65e-05	CcSEcCtD
Topiramate—Pruritus—Clonazepam—epilepsy syndrome	3.6e-06	7.64e-05	CcSEcCtD
Topiramate—Vomiting—Vigabatrin—epilepsy syndrome	3.6e-06	7.64e-05	CcSEcCtD
Topiramate—Skin disorder—Valproic Acid—epilepsy syndrome	3.6e-06	7.64e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.58e-06	7.6e-05	CcSEcCtD
Topiramate—Cough—Pregabalin—epilepsy syndrome	3.58e-06	7.6e-05	CcSEcCtD
Topiramate—Pruritus—Phenytoin—epilepsy syndrome	3.57e-06	7.59e-05	CcSEcCtD
Topiramate—Nausea—Levetiracetam—epilepsy syndrome	3.57e-06	7.58e-05	CcSEcCtD
Topiramate—Rash—Vigabatrin—epilepsy syndrome	3.57e-06	7.57e-05	CcSEcCtD
Topiramate—Dizziness—Felbamate—epilepsy syndrome	3.56e-06	7.57e-05	CcSEcCtD
Topiramate—Dermatitis—Vigabatrin—epilepsy syndrome	3.56e-06	7.57e-05	CcSEcCtD
Topiramate—Pruritus—Oxcarbazepine—epilepsy syndrome	3.55e-06	7.55e-05	CcSEcCtD
Topiramate—Convulsion—Pregabalin—epilepsy syndrome	3.55e-06	7.55e-05	CcSEcCtD
Topiramate—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.55e-06	7.54e-05	CcSEcCtD
Topiramate—Vision blurred—Gabapentin—epilepsy syndrome	3.54e-06	7.53e-05	CcSEcCtD
Topiramate—Headache—Vigabatrin—epilepsy syndrome	3.54e-06	7.52e-05	CcSEcCtD
Topiramate—Hypertension—Pregabalin—epilepsy syndrome	3.54e-06	7.52e-05	CcSEcCtD
Topiramate—Vomiting—Diazepam—epilepsy syndrome	3.54e-06	7.52e-05	CcSEcCtD
Topiramate—Anorexia—Valproic Acid—epilepsy syndrome	3.53e-06	7.49e-05	CcSEcCtD
Topiramate—Tremor—Gabapentin—epilepsy syndrome	3.52e-06	7.48e-05	CcSEcCtD
Topiramate—Rash—Diazepam—epilepsy syndrome	3.51e-06	7.46e-05	CcSEcCtD
Topiramate—Dermatitis—Diazepam—epilepsy syndrome	3.51e-06	7.45e-05	CcSEcCtD
Topiramate—Myalgia—Pregabalin—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Arthralgia—Pregabalin—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Chest pain—Pregabalin—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Dizziness—Zonisamide—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Headache—Diazepam—epilepsy syndrome	3.49e-06	7.41e-05	CcSEcCtD
Topiramate—Anxiety—Pregabalin—epilepsy syndrome	3.48e-06	7.39e-05	CcSEcCtD
Topiramate—Diarrhoea—Clonazepam—epilepsy syndrome	3.48e-06	7.39e-05	CcSEcCtD
Topiramate—Anaemia—Gabapentin—epilepsy syndrome	3.48e-06	7.38e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.47e-06	7.36e-05	CcSEcCtD
Topiramate—Hypotension—Valproic Acid—epilepsy syndrome	3.46e-06	7.35e-05	CcSEcCtD
Topiramate—Asthenia—Carbamazepine—epilepsy syndrome	3.46e-06	7.34e-05	CcSEcCtD
Topiramate—Agitation—Gabapentin—epilepsy syndrome	3.46e-06	7.34e-05	CcSEcCtD
Topiramate—Diarrhoea—Phenytoin—epilepsy syndrome	3.46e-06	7.34e-05	CcSEcCtD
Topiramate—Discomfort—Pregabalin—epilepsy syndrome	3.45e-06	7.32e-05	CcSEcCtD
Topiramate—Nausea—Fosphenytoin—epilepsy syndrome	3.45e-06	7.32e-05	CcSEcCtD
Topiramate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.44e-06	7.3e-05	CcSEcCtD
Topiramate—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.43e-06	7.29e-05	CcSEcCtD
Topiramate—Vomiting—Felbamate—epilepsy syndrome	3.43e-06	7.28e-05	CcSEcCtD
Topiramate—Dry mouth—Pregabalin—epilepsy syndrome	3.42e-06	7.25e-05	CcSEcCtD
Topiramate—Pruritus—Carbamazepine—epilepsy syndrome	3.41e-06	7.24e-05	CcSEcCtD
Topiramate—Rash—Felbamate—epilepsy syndrome	3.4e-06	7.22e-05	CcSEcCtD
Topiramate—Dermatitis—Felbamate—epilepsy syndrome	3.4e-06	7.21e-05	CcSEcCtD
Topiramate—Malaise—Gabapentin—epilepsy syndrome	3.39e-06	7.2e-05	CcSEcCtD
Topiramate—Vertigo—Gabapentin—epilepsy syndrome	3.38e-06	7.17e-05	CcSEcCtD
Topiramate—Headache—Felbamate—epilepsy syndrome	3.38e-06	7.17e-05	CcSEcCtD
Topiramate—Confusional state—Pregabalin—epilepsy syndrome	3.38e-06	7.17e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.37e-06	7.16e-05	CcSEcCtD
Topiramate—Syncope—Gabapentin—epilepsy syndrome	3.37e-06	7.16e-05	CcSEcCtD
Topiramate—Leukopenia—Gabapentin—epilepsy syndrome	3.37e-06	7.15e-05	CcSEcCtD
Topiramate—Dizziness—Clonazepam—epilepsy syndrome	3.36e-06	7.14e-05	CcSEcCtD
Topiramate—Nausea—Vigabatrin—epilepsy syndrome	3.36e-06	7.13e-05	CcSEcCtD
Topiramate—Vomiting—Zonisamide—epilepsy syndrome	3.36e-06	7.12e-05	CcSEcCtD
Topiramate—Insomnia—Valproic Acid—epilepsy syndrome	3.35e-06	7.11e-05	CcSEcCtD
Topiramate—Oedema—Pregabalin—epilepsy syndrome	3.35e-06	7.11e-05	CcSEcCtD
Topiramate—Asthenia—Lamotrigine—epilepsy syndrome	3.34e-06	7.1e-05	CcSEcCtD
Topiramate—Dizziness—Phenytoin—epilepsy syndrome	3.34e-06	7.09e-05	CcSEcCtD
Topiramate—Rash—Zonisamide—epilepsy syndrome	3.33e-06	7.06e-05	CcSEcCtD
Topiramate—Infection—Pregabalin—epilepsy syndrome	3.33e-06	7.06e-05	CcSEcCtD
Topiramate—Paraesthesia—Valproic Acid—epilepsy syndrome	3.33e-06	7.06e-05	CcSEcCtD
Topiramate—Palpitations—Gabapentin—epilepsy syndrome	3.32e-06	7.06e-05	CcSEcCtD
Topiramate—Dermatitis—Zonisamide—epilepsy syndrome	3.32e-06	7.06e-05	CcSEcCtD
Topiramate—Dizziness—Oxcarbazepine—epilepsy syndrome	3.32e-06	7.05e-05	CcSEcCtD
Topiramate—Nausea—Diazepam—epilepsy syndrome	3.31e-06	7.02e-05	CcSEcCtD
Topiramate—Loss of consciousness—Gabapentin—epilepsy syndrome	3.31e-06	7.02e-05	CcSEcCtD
Topiramate—Headache—Zonisamide—epilepsy syndrome	3.31e-06	7.02e-05	CcSEcCtD
Topiramate—Dyspnoea—Valproic Acid—epilepsy syndrome	3.3e-06	7.01e-05	CcSEcCtD
Topiramate—Diarrhoea—Carbamazepine—epilepsy syndrome	3.3e-06	7e-05	CcSEcCtD
Topiramate—Pruritus—Lamotrigine—epilepsy syndrome	3.3e-06	7e-05	CcSEcCtD
Topiramate—Shock—Pregabalin—epilepsy syndrome	3.29e-06	6.99e-05	CcSEcCtD
Topiramate—Somnolence—Valproic Acid—epilepsy syndrome	3.29e-06	6.99e-05	CcSEcCtD
Topiramate—Nervous system disorder—Pregabalin—epilepsy syndrome	3.28e-06	6.97e-05	CcSEcCtD
Topiramate—Cough—Gabapentin—epilepsy syndrome	3.28e-06	6.97e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.28e-06	6.96e-05	CcSEcCtD
Topiramate—Tachycardia—Pregabalin—epilepsy syndrome	3.27e-06	6.94e-05	CcSEcCtD
Topiramate—Dyspepsia—Valproic Acid—epilepsy syndrome	3.26e-06	6.92e-05	CcSEcCtD
Topiramate—Convulsion—Gabapentin—epilepsy syndrome	3.26e-06	6.92e-05	CcSEcCtD
Topiramate—Skin disorder—Pregabalin—epilepsy syndrome	3.25e-06	6.9e-05	CcSEcCtD
Topiramate—Hypertension—Gabapentin—epilepsy syndrome	3.25e-06	6.89e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.24e-06	6.87e-05	CcSEcCtD
Topiramate—Vomiting—Clonazepam—epilepsy syndrome	3.23e-06	6.86e-05	CcSEcCtD
Topiramate—Decreased appetite—Valproic Acid—epilepsy syndrome	3.22e-06	6.83e-05	CcSEcCtD
Topiramate—Vomiting—Phenytoin—epilepsy syndrome	3.21e-06	6.82e-05	CcSEcCtD
Topiramate—Rash—Clonazepam—epilepsy syndrome	3.21e-06	6.81e-05	CcSEcCtD
Topiramate—Dermatitis—Clonazepam—epilepsy syndrome	3.2e-06	6.8e-05	CcSEcCtD
Topiramate—Arthralgia—Gabapentin—epilepsy syndrome	3.2e-06	6.8e-05	CcSEcCtD
Topiramate—Myalgia—Gabapentin—epilepsy syndrome	3.2e-06	6.8e-05	CcSEcCtD
Topiramate—Chest pain—Gabapentin—epilepsy syndrome	3.2e-06	6.8e-05	CcSEcCtD
Topiramate—Nausea—Felbamate—epilepsy syndrome	3.2e-06	6.8e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.2e-06	6.79e-05	CcSEcCtD
Topiramate—Vomiting—Oxcarbazepine—epilepsy syndrome	3.19e-06	6.78e-05	CcSEcCtD
Topiramate—Fatigue—Valproic Acid—epilepsy syndrome	3.19e-06	6.78e-05	CcSEcCtD
Topiramate—Anxiety—Gabapentin—epilepsy syndrome	3.19e-06	6.77e-05	CcSEcCtD
Topiramate—Anorexia—Pregabalin—epilepsy syndrome	3.19e-06	6.77e-05	CcSEcCtD
Topiramate—Dizziness—Carbamazepine—epilepsy syndrome	3.19e-06	6.77e-05	CcSEcCtD
Topiramate—Diarrhoea—Lamotrigine—epilepsy syndrome	3.19e-06	6.77e-05	CcSEcCtD
Topiramate—Headache—Clonazepam—epilepsy syndrome	3.19e-06	6.76e-05	CcSEcCtD
Topiramate—Rash—Phenytoin—epilepsy syndrome	3.19e-06	6.76e-05	CcSEcCtD
Topiramate—Dermatitis—Phenytoin—epilepsy syndrome	3.18e-06	6.76e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.18e-06	6.75e-05	CcSEcCtD
Topiramate—Rash—Oxcarbazepine—epilepsy syndrome	3.17e-06	6.73e-05	CcSEcCtD
Topiramate—Pain—Valproic Acid—epilepsy syndrome	3.17e-06	6.72e-05	CcSEcCtD
Topiramate—Constipation—Valproic Acid—epilepsy syndrome	3.17e-06	6.72e-05	CcSEcCtD
Topiramate—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.17e-06	6.72e-05	CcSEcCtD
Topiramate—Headache—Phenytoin—epilepsy syndrome	3.16e-06	6.72e-05	CcSEcCtD
Topiramate—Discomfort—Gabapentin—epilepsy syndrome	3.16e-06	6.72e-05	CcSEcCtD
Topiramate—Headache—Oxcarbazepine—epilepsy syndrome	3.15e-06	6.68e-05	CcSEcCtD
Topiramate—Nausea—Zonisamide—epilepsy syndrome	3.13e-06	6.65e-05	CcSEcCtD
Topiramate—Dry mouth—Gabapentin—epilepsy syndrome	3.13e-06	6.65e-05	CcSEcCtD
Topiramate—Hypotension—Pregabalin—epilepsy syndrome	3.13e-06	6.64e-05	CcSEcCtD
Topiramate—Confusional state—Gabapentin—epilepsy syndrome	3.1e-06	6.57e-05	CcSEcCtD
Topiramate—Dizziness—Lamotrigine—epilepsy syndrome	3.08e-06	6.54e-05	CcSEcCtD
Topiramate—Oedema—Gabapentin—epilepsy syndrome	3.07e-06	6.52e-05	CcSEcCtD
Topiramate—Vomiting—Carbamazepine—epilepsy syndrome	3.07e-06	6.51e-05	CcSEcCtD
Topiramate—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.05e-06	6.48e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.05e-06	6.48e-05	CcSEcCtD
Topiramate—Infection—Gabapentin—epilepsy syndrome	3.05e-06	6.47e-05	CcSEcCtD
Topiramate—Rash—Carbamazepine—epilepsy syndrome	3.04e-06	6.45e-05	CcSEcCtD
Topiramate—Dermatitis—Carbamazepine—epilepsy syndrome	3.04e-06	6.45e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.03e-06	6.43e-05	CcSEcCtD
Topiramate—Insomnia—Pregabalin—epilepsy syndrome	3.03e-06	6.43e-05	CcSEcCtD
Topiramate—Nausea—Clonazepam—epilepsy syndrome	3.02e-06	6.41e-05	CcSEcCtD
Topiramate—Headache—Carbamazepine—epilepsy syndrome	3.02e-06	6.41e-05	CcSEcCtD
Topiramate—Shock—Gabapentin—epilepsy syndrome	3.02e-06	6.41e-05	CcSEcCtD
Topiramate—Nervous system disorder—Gabapentin—epilepsy syndrome	3.01e-06	6.39e-05	CcSEcCtD
Topiramate—Paraesthesia—Pregabalin—epilepsy syndrome	3.01e-06	6.38e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.01e-06	6.38e-05	CcSEcCtD
Topiramate—Nausea—Phenytoin—epilepsy syndrome	3e-06	6.37e-05	CcSEcCtD
Topiramate—Tachycardia—Gabapentin—epilepsy syndrome	3e-06	6.36e-05	CcSEcCtD
Topiramate—Dyspnoea—Pregabalin—epilepsy syndrome	2.98e-06	6.34e-05	CcSEcCtD
Topiramate—Nausea—Oxcarbazepine—epilepsy syndrome	2.98e-06	6.34e-05	CcSEcCtD
Topiramate—Skin disorder—Gabapentin—epilepsy syndrome	2.98e-06	6.33e-05	CcSEcCtD
Topiramate—Somnolence—Pregabalin—epilepsy syndrome	2.98e-06	6.32e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.97e-06	6.3e-05	CcSEcCtD
Topiramate—Vomiting—Lamotrigine—epilepsy syndrome	2.96e-06	6.29e-05	CcSEcCtD
Topiramate—Urticaria—Valproic Acid—epilepsy syndrome	2.94e-06	6.25e-05	CcSEcCtD
Topiramate—Rash—Lamotrigine—epilepsy syndrome	2.94e-06	6.24e-05	CcSEcCtD
Topiramate—Dermatitis—Lamotrigine—epilepsy syndrome	2.94e-06	6.23e-05	CcSEcCtD
Topiramate—Body temperature increased—Valproic Acid—epilepsy syndrome	2.93e-06	6.21e-05	CcSEcCtD
Topiramate—Abdominal pain—Valproic Acid—epilepsy syndrome	2.93e-06	6.21e-05	CcSEcCtD
Topiramate—Anorexia—Gabapentin—epilepsy syndrome	2.93e-06	6.21e-05	CcSEcCtD
Topiramate—Headache—Lamotrigine—epilepsy syndrome	2.92e-06	6.2e-05	CcSEcCtD
Topiramate—Decreased appetite—Pregabalin—epilepsy syndrome	2.91e-06	6.18e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.89e-06	6.14e-05	CcSEcCtD
Topiramate—Fatigue—Pregabalin—epilepsy syndrome	2.89e-06	6.13e-05	CcSEcCtD
Topiramate—Hypotension—Gabapentin—epilepsy syndrome	2.87e-06	6.09e-05	CcSEcCtD
Topiramate—Nausea—Carbamazepine—epilepsy syndrome	2.86e-06	6.08e-05	CcSEcCtD
Topiramate—Constipation—Pregabalin—epilepsy syndrome	2.86e-06	6.08e-05	CcSEcCtD
Topiramate—Pain—Pregabalin—epilepsy syndrome	2.86e-06	6.08e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.8e-06	5.94e-05	CcSEcCtD
Topiramate—Insomnia—Gabapentin—epilepsy syndrome	2.78e-06	5.89e-05	CcSEcCtD
Topiramate—Nausea—Lamotrigine—epilepsy syndrome	2.77e-06	5.88e-05	CcSEcCtD
Topiramate—Feeling abnormal—Pregabalin—epilepsy syndrome	2.76e-06	5.86e-05	CcSEcCtD
Topiramate—Paraesthesia—Gabapentin—epilepsy syndrome	2.76e-06	5.85e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.74e-06	5.81e-05	CcSEcCtD
Topiramate—Dyspnoea—Gabapentin—epilepsy syndrome	2.74e-06	5.81e-05	CcSEcCtD
Topiramate—Somnolence—Gabapentin—epilepsy syndrome	2.73e-06	5.79e-05	CcSEcCtD
Topiramate—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.73e-06	5.79e-05	CcSEcCtD
Topiramate—Dyspepsia—Gabapentin—epilepsy syndrome	2.7e-06	5.74e-05	CcSEcCtD
Topiramate—Decreased appetite—Gabapentin—epilepsy syndrome	2.67e-06	5.67e-05	CcSEcCtD
Topiramate—Urticaria—Pregabalin—epilepsy syndrome	2.66e-06	5.65e-05	CcSEcCtD
Topiramate—Asthenia—Valproic Acid—epilepsy syndrome	2.66e-06	5.64e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.65e-06	5.63e-05	CcSEcCtD
Topiramate—Fatigue—Gabapentin—epilepsy syndrome	2.65e-06	5.62e-05	CcSEcCtD
Topiramate—Abdominal pain—Pregabalin—epilepsy syndrome	2.65e-06	5.62e-05	CcSEcCtD
Topiramate—Body temperature increased—Pregabalin—epilepsy syndrome	2.65e-06	5.62e-05	CcSEcCtD
Topiramate—Pain—Gabapentin—epilepsy syndrome	2.63e-06	5.57e-05	CcSEcCtD
Topiramate—Constipation—Gabapentin—epilepsy syndrome	2.63e-06	5.57e-05	CcSEcCtD
Topiramate—Pruritus—Valproic Acid—epilepsy syndrome	2.62e-06	5.56e-05	CcSEcCtD
Topiramate—Diarrhoea—Valproic Acid—epilepsy syndrome	2.53e-06	5.38e-05	CcSEcCtD
Topiramate—Feeling abnormal—Gabapentin—epilepsy syndrome	2.53e-06	5.37e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.51e-06	5.33e-05	CcSEcCtD
Topiramate—Hypersensitivity—Pregabalin—epilepsy syndrome	2.47e-06	5.24e-05	CcSEcCtD
Topiramate—Dizziness—Valproic Acid—epilepsy syndrome	2.45e-06	5.2e-05	CcSEcCtD
Topiramate—Urticaria—Gabapentin—epilepsy syndrome	2.44e-06	5.18e-05	CcSEcCtD
Topiramate—Body temperature increased—Gabapentin—epilepsy syndrome	2.43e-06	5.15e-05	CcSEcCtD
Topiramate—Abdominal pain—Gabapentin—epilepsy syndrome	2.43e-06	5.15e-05	CcSEcCtD
Topiramate—Asthenia—Pregabalin—epilepsy syndrome	2.4e-06	5.1e-05	CcSEcCtD
Topiramate—Pruritus—Pregabalin—epilepsy syndrome	2.37e-06	5.03e-05	CcSEcCtD
Topiramate—Vomiting—Valproic Acid—epilepsy syndrome	2.35e-06	5e-05	CcSEcCtD
Topiramate—Rash—Valproic Acid—epilepsy syndrome	2.33e-06	4.96e-05	CcSEcCtD
Topiramate—Dermatitis—Valproic Acid—epilepsy syndrome	2.33e-06	4.95e-05	CcSEcCtD
Topiramate—Headache—Valproic Acid—epilepsy syndrome	2.32e-06	4.92e-05	CcSEcCtD
Topiramate—Diarrhoea—Pregabalin—epilepsy syndrome	2.29e-06	4.86e-05	CcSEcCtD
Topiramate—Hypersensitivity—Gabapentin—epilepsy syndrome	2.26e-06	4.8e-05	CcSEcCtD
Topiramate—Dizziness—Pregabalin—epilepsy syndrome	2.21e-06	4.7e-05	CcSEcCtD
Topiramate—Asthenia—Gabapentin—epilepsy syndrome	2.2e-06	4.68e-05	CcSEcCtD
Topiramate—Nausea—Valproic Acid—epilepsy syndrome	2.2e-06	4.67e-05	CcSEcCtD
Topiramate—Pruritus—Gabapentin—epilepsy syndrome	2.17e-06	4.61e-05	CcSEcCtD
Topiramate—Vomiting—Pregabalin—epilepsy syndrome	2.13e-06	4.52e-05	CcSEcCtD
Topiramate—Rash—Pregabalin—epilepsy syndrome	2.11e-06	4.48e-05	CcSEcCtD
Topiramate—Dermatitis—Pregabalin—epilepsy syndrome	2.11e-06	4.48e-05	CcSEcCtD
Topiramate—Diarrhoea—Gabapentin—epilepsy syndrome	2.1e-06	4.46e-05	CcSEcCtD
Topiramate—Headache—Pregabalin—epilepsy syndrome	2.1e-06	4.45e-05	CcSEcCtD
Topiramate—Dizziness—Gabapentin—epilepsy syndrome	2.03e-06	4.31e-05	CcSEcCtD
Topiramate—Nausea—Pregabalin—epilepsy syndrome	1.99e-06	4.22e-05	CcSEcCtD
Topiramate—Vomiting—Gabapentin—epilepsy syndrome	1.95e-06	4.14e-05	CcSEcCtD
Topiramate—Rash—Gabapentin—epilepsy syndrome	1.94e-06	4.11e-05	CcSEcCtD
Topiramate—Dermatitis—Gabapentin—epilepsy syndrome	1.93e-06	4.11e-05	CcSEcCtD
Topiramate—Headache—Gabapentin—epilepsy syndrome	1.92e-06	4.08e-05	CcSEcCtD
Topiramate—Nausea—Gabapentin—epilepsy syndrome	1.82e-06	3.87e-05	CcSEcCtD
Topiramate—CA4—Metabolism—PLCB1—epilepsy syndrome	6.68e-07	1.79e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—TH—epilepsy syndrome	6.65e-07	1.79e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.65e-07	1.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	6.62e-07	1.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	6.58e-07	1.77e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ADRA2A—epilepsy syndrome	6.53e-07	1.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.53e-07	1.75e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.53e-07	1.75e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—BCHE—epilepsy syndrome	6.5e-07	1.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	6.49e-07	1.74e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC2A1—epilepsy syndrome	6.47e-07	1.74e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.47e-07	1.74e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PLCB1—epilepsy syndrome	6.4e-07	1.72e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.4e-07	1.72e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—TH—epilepsy syndrome	6.38e-07	1.71e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.35e-07	1.7e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AGT—epilepsy syndrome	6.3e-07	1.69e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AGT—epilepsy syndrome	6.3e-07	1.69e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.27e-07	1.68e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—GPX1—epilepsy syndrome	6.21e-07	1.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC2A1—epilepsy syndrome	6.21e-07	1.66e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—epilepsy syndrome	6.17e-07	1.66e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—epilepsy syndrome	6.17e-07	1.66e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PLCB1—epilepsy syndrome	6.14e-07	1.65e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—TH—epilepsy syndrome	6.12e-07	1.64e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—epilepsy syndrome	6.11e-07	1.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	6.06e-07	1.63e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2D6—epilepsy syndrome	6.03e-07	1.62e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—epilepsy syndrome	6.02e-07	1.62e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.97e-07	1.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	5.94e-07	1.59e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.92e-07	1.59e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AGT—epilepsy syndrome	5.88e-07	1.58e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AGT—epilepsy syndrome	5.88e-07	1.58e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	5.86e-07	1.57e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—epilepsy syndrome	5.76e-07	1.55e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—epilepsy syndrome	5.76e-07	1.55e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ADRA2A—epilepsy syndrome	5.74e-07	1.54e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.73e-07	1.54e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—BCHE—epilepsy syndrome	5.72e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FAR1—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PDXK—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CERS1—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADK—epilepsy syndrome	5.71e-07	1.53e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—SRC—epilepsy syndrome	5.64e-07	1.51e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SRC—epilepsy syndrome	5.55e-07	1.49e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—HMOX1—epilepsy syndrome	5.55e-07	1.49e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—epilepsy syndrome	5.49e-07	1.47e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.48e-07	1.47e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAT—epilepsy syndrome	5.48e-07	1.47e-05	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.48e-07	1.47e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC2A1—epilepsy syndrome	5.46e-07	1.46e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AGT—epilepsy syndrome	5.45e-07	1.46e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	5.43e-07	1.46e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	5.41e-07	1.45e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PLCB1—epilepsy syndrome	5.4e-07	1.45e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—TH—epilepsy syndrome	5.38e-07	1.44e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—epilepsy syndrome	5.34e-07	1.43e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—epilepsy syndrome	5.33e-07	1.43e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—HMOX1—epilepsy syndrome	5.32e-07	1.43e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—epilepsy syndrome	5.3e-07	1.42e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—epilepsy syndrome	5.3e-07	1.42e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAT—epilepsy syndrome	5.25e-07	1.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	5.22e-07	1.4e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GAMT—epilepsy syndrome	5.22e-07	1.4e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PNPO—epilepsy syndrome	5.22e-07	1.4e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	5.22e-07	1.4e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.22e-07	1.4e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.17e-07	1.39e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—epilepsy syndrome	5.11e-07	1.37e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—epilepsy syndrome	5.1e-07	1.37e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—RELA—epilepsy syndrome	5.04e-07	1.35e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAT—epilepsy syndrome	5.04e-07	1.35e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.01e-07	1.34e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPX1—epilepsy syndrome	4.96e-07	1.33e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—epilepsy syndrome	4.95e-07	1.33e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—epilepsy syndrome	4.95e-07	1.33e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—epilepsy syndrome	4.9e-07	1.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—QDPR—epilepsy syndrome	4.85e-07	1.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA4—epilepsy syndrome	4.85e-07	1.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	4.84e-07	1.3e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—epilepsy syndrome	4.83e-07	1.3e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—epilepsy syndrome	4.83e-07	1.3e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPX1—epilepsy syndrome	4.75e-07	1.27e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—epilepsy syndrome	4.71e-07	1.26e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—epilepsy syndrome	4.59e-07	1.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COX3—epilepsy syndrome	4.56e-07	1.22e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPX1—epilepsy syndrome	4.55e-07	1.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA13—epilepsy syndrome	4.53e-07	1.22e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—epilepsy syndrome	4.51e-07	1.21e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—epilepsy syndrome	4.51e-07	1.21e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—epilepsy syndrome	4.49e-07	1.2e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAT—epilepsy syndrome	4.43e-07	1.19e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AGT—epilepsy syndrome	4.35e-07	1.17e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	4.33e-07	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	4.33e-07	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	4.33e-07	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PFKL—epilepsy syndrome	4.33e-07	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	4.33e-07	1.16e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—epilepsy syndrome	4.31e-07	1.16e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	4.3e-07	1.15e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—epilepsy syndrome	4.26e-07	1.14e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—epilepsy syndrome	4.23e-07	1.13e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—epilepsy syndrome	4.23e-07	1.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.2e-07	1.13e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—epilepsy syndrome	4.18e-07	1.12e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AGT—epilepsy syndrome	4.17e-07	1.12e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—epilepsy syndrome	4.08e-07	1.1e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—epilepsy syndrome	4e-07	1.07e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AGT—epilepsy syndrome	3.99e-07	1.07e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—epilepsy syndrome	3.96e-07	1.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NEU1—epilepsy syndrome	3.96e-07	1.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ATIC—epilepsy syndrome	3.96e-07	1.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UPB1—epilepsy syndrome	3.96e-07	1.06e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—epilepsy syndrome	3.95e-07	1.06e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—epilepsy syndrome	3.95e-07	1.06e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.92e-07	1.05e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—epilepsy syndrome	3.91e-07	1.05e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	3.86e-07	1.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	3.81e-07	1.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	3.68e-07	9.87e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GBE1—epilepsy syndrome	3.68e-07	9.87e-06	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—epilepsy syndrome	3.66e-07	9.81e-06	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—epilepsy syndrome	3.66e-07	9.81e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.59e-07	9.64e-06	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.59e-07	9.62e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—AGT—epilepsy syndrome	3.51e-07	9.42e-06	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—epilepsy syndrome	3.51e-07	9.41e-06	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—epilepsy syndrome	3.5e-07	9.4e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	3.46e-07	9.28e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—epilepsy syndrome	3.44e-07	9.23e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.43e-07	9.21e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	3.36e-07	9.02e-06	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—epilepsy syndrome	3.36e-07	9.02e-06	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—epilepsy syndrome	3.33e-07	8.95e-06	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—epilepsy syndrome	3.31e-07	8.88e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NT5E—epilepsy syndrome	3.28e-07	8.79e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALAD—epilepsy syndrome	3.28e-07	8.79e-06	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—epilepsy syndrome	3.2e-07	8.58e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.14e-07	8.42e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.14e-07	8.42e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.14e-07	8.42e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.14e-07	8.42e-06	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.13e-07	8.41e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	3.13e-07	8.39e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	3.13e-07	8.39e-06	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—epilepsy syndrome	3.06e-07	8.22e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	3.06e-07	8.21e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADSL—epilepsy syndrome	3e-07	8.04e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—epilepsy syndrome	2.96e-07	7.93e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLUL—epilepsy syndrome	2.94e-07	7.89e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.92e-07	7.83e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.92e-07	7.83e-06	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—epilepsy syndrome	2.92e-07	7.83e-06	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.91e-07	7.81e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.89e-07	7.74e-06	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—epilepsy syndrome	2.8e-07	7.5e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.74e-07	7.36e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.7e-07	7.24e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—epilepsy syndrome	2.69e-07	7.23e-06	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—epilepsy syndrome	2.68e-07	7.19e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.62e-07	7.03e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.6e-07	6.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.6e-07	6.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.6e-07	6.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.6e-07	6.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.6e-07	6.98e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.52e-07	6.75e-06	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	2.46e-07	6.61e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.38e-07	6.38e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.38e-07	6.38e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.38e-07	6.38e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.37e-07	6.36e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.37e-07	6.36e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—epilepsy syndrome	2.36e-07	6.32e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.29e-07	6.14e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.21e-07	5.93e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.21e-07	5.93e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.21e-07	5.92e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.16e-07	5.8e-06	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—epilepsy syndrome	2.13e-07	5.7e-06	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—epilepsy syndrome	2.13e-07	5.7e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.08e-07	5.58e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.02e-07	5.43e-06	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—epilepsy syndrome	1.98e-07	5.32e-06	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—epilepsy syndrome	1.98e-07	5.32e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.97e-07	5.29e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.97e-07	5.29e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.93e-07	5.18e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.88e-07	5.05e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.88e-07	5.05e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.87e-07	5.02e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.86e-07	4.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.84e-07	4.94e-06	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—epilepsy syndrome	1.84e-07	4.93e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.8e-07	4.84e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.77e-07	4.74e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.74e-07	4.66e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.69e-07	4.54e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.69e-07	4.53e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.62e-07	4.36e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.61e-07	4.31e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.6e-07	4.3e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.58e-07	4.23e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.53e-07	4.1e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.51e-07	4.05e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TH—epilepsy syndrome	1.51e-07	4.04e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.48e-07	3.98e-06	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—epilepsy syndrome	1.47e-07	3.93e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.43e-07	3.82e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.43e-07	3.82e-06	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—epilepsy syndrome	1.41e-07	3.77e-06	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—epilepsy syndrome	1.35e-07	3.62e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.26e-07	3.37e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.24e-07	3.33e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.21e-07	3.23e-06	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—epilepsy syndrome	1.18e-07	3.18e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.16e-07	3.12e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.13e-07	3.04e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.13e-07	3.02e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.12e-07	3.01e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.02e-07	2.72e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AGT—epilepsy syndrome	9.83e-08	2.64e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.67e-08	2.59e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—epilepsy syndrome	9.63e-08	2.58e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.63e-08	2.58e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.18e-08	2.46e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.08e-08	2.44e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TH—epilepsy syndrome	9.05e-08	2.43e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.27e-08	2.22e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.55e-08	2.03e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.54e-08	2.02e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.45e-08	2e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.25e-08	1.95e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.74e-08	1.81e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.6e-08	1.77e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.91e-08	1.59e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.79e-08	1.55e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.98e-08	1.33e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.54e-08	1.22e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.97e-08	1.06e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.32e-08	8.9e-07	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.99e-08	5.35e-07	CbGpPWpGaD
